Prevnar, the first pneumococcal vaccine that can be used in children under 2

Wyeth-Ayerst is now marketing Prevnar, the first pneumococcal vaccine that can be used in children under 2.

These kids have the highest risk of invasive pneumococcal disease.

Prevnar is very effective and will be used for preventing pneumococcal bacteremia...meningitis...and pneumonia.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote